Riskpilot← Back to searchSign inGet full accessNurmirohto Oy
OYActiveY-tunnus 3235655-4Untuvaisenkuja 4-B42Other human health activities n.e.c. · NACE 8699Est. 2021— employees
Revenue 2025
EUR 1,7M
+2% vs 2024
EBITDA margin
30.9%
-82% vs 2024
Equity ratio
96.0%
Financial strength
Net profit 2025
EUR 419K
+9% vs 2024
| Revenue | EUR 1,7M | +2% |
| EBITDA | EUR 517K | -82% |
| Net profit | EUR 419K | +9% |
| Total assets | EUR 1,5M | +25% |
| Equity | EUR 1,4M | +30% |
| Employees | — | — |
Legal name
Nurmirohto Oy
Y-tunnus number
3235655-4
Legal form
Osakeyhtiö
NACE code
8699 · Other human health activities n.e.c.
Founded
14. syyskuuta 2021
Share capital
EUR 0
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Company purpose
Yhtiön toimiala on terveystuotteiden, lääkkeiden käyttöön tarvittavien välineiden ja tarvikkeiden, nikotiinivalmisteiden, luontaistuotteiden, ravintolisien, elintarvikkeiden ja kosmeettisten valmisteiden ja muiden ns. vapaankaupan tuotteiden vähittäiskauppa, tukkukauppa, valmistus, maahantuonti ja maastavienti. Yhtiön toimialaan kuuluvat myös lääkehoidon tukipalvelut, kosmetologin palvelut, konsultointi- ja koulutuspalvelut ja henkilöstövuokraus, sekä terapia- ja hyvinvointipalvelut.
Lisäksi yhtiön toimialaan kuuluvat kiinteistöjen ja maa-alueiden, osuuksien, osakkeiden ja muiden arvopapereiden ostaminen, hallitseminen ja myyminen.
Address
Untuvaisenkuja 4-B42
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 1 593 | 1 556 | 1 641 | 1 674 |
| Staff expenses | — | — | — | — |
| EBITDA | 2 644 | 2 647 | 2 808 | 517 |
| Depreciation & amort. | — | — | — | — |
| EBIT | 542 | 466 | 477 | 517 |
| Net financials | −0 | — | −0 | −0 |
| Profit before tax | 542 | 466 | 481 | 523 |
| Tax | 108 | 93 | 96 | −105 |
| Net profit | 433 | 372 | 385 | 419 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 498 | 890 | 1 190 | 1 485 |
| Equity | 433 | 771 | 1 094 | 1 426 |
| Long-term debt | — | — | — | — |
| Short-term debt | 65 | 119 | 96 | 60 |
| Total debt | 65 | 119 | 96 | 60 |
EBITDA margin
30.9%
This company
15.8%
Market median
+96% vs market
20222025
Equity ratio
96.0%
This company
38.2%
Market median
+151% vs market
20222025
Return on equity
29.4%
This company
18.4%
Market median
+60% vs market
20222025
Net profit margin
25.0%
This company
8.1%
Market median
+209% vs market
20222025
Asset turnover
1.13×
This company
1.12×
Market median
+1% vs market
20222025
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20222025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2021-09-14 – 2022-12-31
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
SM Chief Executive Officer | Chief Executive Officer | 2021 |
JB Audit | Audit | 2021 |
TT Deputy auditor | Deputy auditor | 2021 |
PN Deputy Member | Deputy Member | 2021 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Nurmirohto Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Satu Marjaana Nurmilaukas | Chief Executive Officer | 0 companies |
| Jan-Erik Björklöf | Audit | 0 companies |
| Timo Tapio Post | Deputy auditor | 0 companies |
| Pekka Nurmilaukas | Deputy Member | 0 companies |